Health Sciences Group, Inc. HESG Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Health Sciences Group, Inc. HESG Company Overview 

Stock Message Board http://investorshangout.com/search?q=HESG&...mp;yt1=Go!

Health Sciences Group, Inc. HESG Current Price and Quotes
Last Price 0.0001
Previous Close 0.0001 Open 0.0001
Daily Range 0.0001 - 0.0001 52wk Range 0.0003 - 0.0001
Volume 431,000 Dividend N/A
Average Vol (3m) 1,359,566 Yield N/A
Health Sciences Group, Inc. HESG
Company Information

14331 Euclid St. Suite 207
Garden Grove, CA 92843

Website: http://www.hesciencesgroup.com
Phone: 800-549-3067
Email: nle@hesciencesgroup.com

Health Sciences Group, Inc. HESG
Health Sciences Group is positioning itself to be a dominant player in the fast evolving world of healthcare mobile apps development. Vietnam is our perfect choice to attract expert talent and reasonable wages the area has to offer. With our cost cutting and reduced overhead expenses, Health Sciences Group will quickly be in positive territory for several immediate acquisitions to rapidly expand our global product range.

Health Sciences Group, Inc. HESG
Financial Reportings and Disclosures

Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Nov 16, 2012
Audited Financials Unaudited
Latest Report Dec 31, 2012 Annual Report
CIK 0001127696
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 2860 - Industrial Organic Chemicals
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 2000
Employees 10 a/o Dec 08, 2008
Company Officers/Contacts

Nhue Le President, Secretary, Treasurer
Company Directors

Nhue Le
Company Notes

Formerly=iGoHealthy.com, Inc. until 9-01
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Law Offices of Joseph L. Pittera
2214 Torrance Boulevard, Suite 101
Torrance, CA, 90501
United States

Investor Relations Firm
Not Available

Health Sciences Group, Inc. HESG
HESG Security Details

Share Structure

Market Value1 $1,870,936 a/o Sep 17, 2013
Shares Outstanding 18,709,356,099 a/o Dec 31, 2012
Float 13,299,759,161 a/o Dec 31, 2012
Authorized Shares 20,000,000,000 a/o Dec 31, 2012
Par Value  0.001
Shareholders

Shareholders of Record 278 a/o Nov 15, 2012
Short Selling Data

Short Interest 0 (-100%)
Jun 30, 2010
Significant Failures to Deliver  No
Transfer Agent(s)

Pacific Stock Transfer Co.

Health Sciences Group, Inc. HESG Recent News

Health Sciences Group, Inc. HESG Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue 358 197
Cost of Revenue 275 131
Gross Profit 84 66
Operating Expenses

Research and Development - -
Sales, General and Admin. 128 121
Non-Recurring Items - -
Other 10 11
Operating Income (54) (66)
Income From Continuing Operations

Add'l Income/Expense Items - -
Earnings Before Interest and Tax (54) (66)
Interest Expense - -
Earnings Before Tax (54) (66)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (54) (66)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (54) (66)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (54) (66)

HESG Health Sciences Group, Inc. Research DD Guide

HESG Health Sciences Group, Inc. Stock Message Board http://investorshangout.com/search?q=HESG&...mp;yt0=Go!
HESG Health Sciences Group, Inc. Stock Quote http://www.otcmarkets.com/stock/HESG/quote
HESG Health Sciences Group, Inc. Stock Chart http://www.otcmarkets.com/stock/HESG/chart
HESG Health Sciences Group, Inc. Company Info http://www.otcmarkets.com/stock/HESG/company-info
HESG Health Sciences Group, Inc. Recent News http://www.otcmarkets.com/stock/HESG/news
HESG Health Sciences Group, Inc. Financials http://www.otcmarkets.com/stock/HESG/financials
HESG Health Sciences Group, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/HESG/filings
HESG Health Sciences Group, Inc. Short Sales http://www.otcmarkets.com/stock/HESG/short-sales
HESG Health Sciences Group, Inc. Insider Disclosure http://www.otcmarkets.com/stock/HESG/insider-transactions
HESG Health Sciences Group, Inc. Research Reports http://www.otcmarkets.com/stock/HESG/research
HESG Health Sciences Group, Inc. Summary http://finance.yahoo.com/q?s=HESG
HESG Health Sciences Group, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=HESG+Historical+Prices
HESG Health Sciences Group, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=HESG
HESG Health Sciences Group, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=HESG+Basic+Chart
HESG Health Sciences Group, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=HESG+Basic+Tech.+Analysis
HESG Health Sciences Group, Inc. Headlines http://finance.yahoo.com/q/h?s=HESG+Headlines
HESG Health Sciences Group, Inc. Press Releases http://finance.yahoo.com/q/p?s=HESG+Press+Releases
HESG Health Sciences Group, Inc. Company Profile http://finance.yahoo.com/q/pr?s=HESG+Profile
HESG Health Sciences Group, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=HESG+Key+Statistics
HESG Health Sciences Group, Inc. Industry http://finance.yahoo.com/q/in?s=HESG+Industry
HESG Health Sciences Group, Inc. Major Holders http://finance.yahoo.com/q/mh?s=HESG+Major+Holders
HESG Health Sciences Group, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=HESG+Insider+Transactions
HESG Health Sciences Group, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=HESG+Insider+Roster
HESG Health Sciences Group, Inc. Income Statement http://finance.yahoo.com/q/is?s=HESG
HESG Health Sciences Group, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=HESG
HESG Health Sciences Group, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=HESG+Cash+Flow&annual
HESG Health Sciences Group, Inc. Nasdaq http://www.nasdaq.com/symbol/HESG
HESG Health Sciences Group, Inc. Market Watch http://www.marketwatch.com/investing/stock/HESG
HESG Health Sciences Group, Inc. Bloomberg http://www.bloomberg.com/quote/HESG:US
HESG Health Sciences Group, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=HESG
HESG Health Sciences Group, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=HESG
HESG Health Sciences Group, Inc. Barchart http://www.barchart.com/quotes/stocks/HESG
HESG Health Sciences Group, Inc. OTC Short Report http://otcshortreport.com/index.php?index=HESG
HESG Health Sciences Group, Inc. Investopedia http://www.investopedia.com/markets/stocks/HESG/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Veriforce Expands Its Mission with Highwire Acquisition

Updated Category News Views 471

Veriforce Expands Its Mission with Highwire Acquisition The combined expertise delivers stronger safety, compliance, and financial risk management for construction projects worldwide Veriforce, a leader in contractor management and supply chain risk management, has recently announced its acquisition of Highwire. This acquisition is significant in the realm of contractor...

Continue Reading
Tyra Biosciences Achieves Key Preclinical Results, Analysts Upgrades

Updated Category News Views 104

Tyra Biosciences Receives Analyst Upgrade BofA Securities has recently upgraded Tyra Biosciences (NASDAQ: TYRA), a clinical-stage biotechnology firm specializing in the creation of next-generation precision medicines. This upgrade highlights investor optimism as the company demonstrates promising results in its drug development process. Focus on Precision Medicine in...

Continue Reading
ConnX Partners with SEPTA for Enhanced Cloud Communication

Updated Category News Views 254

ConnX landed a hefty contract back in 2024 with the Southeastern Pennsylvania Transportation Authority (SEPTA) for a major overhaul of their communications network. The deal’s supposed to create a seamless communication experience, but you know how these things go—desks are skeptical about the actual impact. SEPTA's Communication Crisis: Is Cloud the Answer? SEPTA,...

Continue Reading
Kinepolis Group Announces Upcoming Dividend Payment Details

Updated Category News Views 197

Kinepolis Group Dividend Announcement The Kinepolis Group NV is pleased to inform its shareholders of an upcoming dividend payout, a noteworthy event for investors looking to maximize their returns. Dividend Payment Details The company has officially announced a gross dividend of €0.55 per share. After the deduction of the standard 30% withholding tax, shareholders will...

Continue Reading
Cargotec Board Restructures Ahead of Exciting Name Change

Updated Category News Views 229

Cargotec's Board of Directors Restructuring Meeting Highlights Cargotec Corporation has made significant decisions during its recent Board of Directors meeting, as it prepares for exciting changes ahead. Notably, the Board has elected Jukka Moisio as Chair, continuing a strong leadership footprint. Alongside him, Casimir Lindholm has been appointed Vice Chair, effective...

Continue Reading